Shamburg News · 8-K filed Oct 16, 2026, 5:03 PM EDT
Iambic Therapeutics Adopts Restated Charter and Bylaws in Connection With IPO
IAM · Iambic Therapeutics, Inc.
- Other
- Materiality: low
On October 16, 2026, Iambic Therapeutics, Inc. filed an amended and restated certificate of incorporation with the Delaware Secretary of State in connection with the completion of its initial public offering. The company also adopted amended and restated bylaws effective October 16, 2026. The company furnished a Regulation FD disclosure noting it may use its website, social media and other channels to disclose material information.
Source: SEC EDGAR, Form 8-K, Items 5.03, 7.01, 9.01, accession 0001193125-26-424242.
Written from the filing by Shamburg Markets. Figures are as reported by the company.